Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013762-23-002553
Filing Date
2023-10-06
Accepted
2023-10-06 16:34:03
Documents
2
Group Members
PASECO APS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea185892-13ga1abildga_reno.htm SC 13G/A 82336
2 JOINT FILING AGREEMENT ea185892ex99-1_renovaro.htm EX-99.1 4962
  Complete submission text file 0001013762-23-002553.txt   88943
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Subject) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-86428 | Film No.: 231314607
SIC: 2834 Pharmaceutical Preparations

Mailing Address VEDBAEK STRANDVEJ 506 VEDBAEK G7 2950
Business Address
Abildgaard Ole (Filed by) CIK: 0001994976 (see all company filings)

Type: SC 13G/A